Trials / Completed
CompletedNCT00471224
A Prospective Safety Follow Up Study Of Subjects Enrolled In Study A4321001 And Who Have Received Drug Product
A Prospective Safety Follow Up Study Of Subjects Enrolled In Study A4321001 And Who Have Received Formulated Drug Product (LOT 8716-098).
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 16 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 55 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This protocol intends to detail investigations necessary to evaluate the ocular safety of subjects enrolled in study A4321001 and who have received formulated Drug Product (Lot 8716-098).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observational Trial | No intervention is being used in this study. |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2008-11-01
- Completion
- 2008-11-01
- First posted
- 2007-05-09
- Last updated
- 2011-02-17
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00471224. Inclusion in this directory is not an endorsement.